Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

Published:2023-11 Issue:11 Volume:29 Page:699.e1-699.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Xu Ziheng,Choi Jaebok^ORCID,Cooper Matthew,King Jeffrey^ORCID,Fiala Mark A.^ORCID,Liu Jingxia,Pusic Iskra,Romee Rizwan,Cashen Amanda,Jacoby Meagan A.,Stockerl-Goldstein Keith^ORCID,Abboud Camille,Vij Ravi,Uy Geoffrey^ORCID,Westervelt Peter,Walter Matthew J.^ORCID,DiPersio John F.,Schroeder Mark A.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference40 articles.

1. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

2. Risk and prognostic factors for acute GVHD based on NIH consensus criteria;Lee;Bone Marrow Transplant,2013

3. Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors;Lazaryan;Biol Blood Marrow Transplant,2016

4. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation;Yu;Curr Med Res Opin,2019

5. The role of regulatory T cells in graft-versus-host disease management;Whangbo;Expert Rev Hematol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles of epigenetic regulation in graft-versus-host disease;Biomedicine & Pharmacotherapy;2024-06